PMID: 9194242Jun 1, 1997Paper

Costs and benefits of improving tuberculosis control: the case of Thailand

Social Science & Medicine
H SawertM C Raviglione

Abstract

The study evaluates the economic costs and benefits of improving tuberculosis control interventions in Thailand. Provider costs are determined on the basis of marginal treatment costs for varying case numbers and estimates of the cost of required infrastructure changes. Indirect costs are calculated as income lost due to morbidity and premature mortality. An epidemiological model is used to calculate case numbers and mortality under current control conditions and a scenario of improved control. An improved control strategy initially leads to a higher number of detected cases. For longer projection periods, the epidemiological impact of curing a higher proportion of infectious sources results in lower case numbers than those expected without programme improvement. Model simulations show a reduction of total annual case numbers through improved control measures by an average 45% after a simulation period of 20 years. The corresponding societal savings in form of reduced indirect costs from the disease are U.S.$2.4 billion. Reductions in direct provider costs can be expected as a result of decreased numbers of detected cases for longer evaluation periods, as well as a lower proportion of multi-drug-resistant cases. The mean value ...Continue Reading

References

Jan 1, 1986·Social Science & Medicine·H N Barnum
Mar 1, 1989·International Journal of Epidemiology·M R JoesoefP T Jiptoherijanto
Mar 1, 1967·American Journal of Public Health and the Nation's Health·D P Rice
Oct 5, 1995·The New England Journal of Medicine·E E TelzakG Turett
Jul 27, 1995·The New England Journal of Medicine·T R FriedenM A Hamburg
Apr 1, 1994·International Journal of Epidemiology·M SchulzerJ M Fitzgerald
Apr 28, 1994·The New England Journal of Medicine·S E WeisB H Foresman
Feb 25, 1993·The New England Journal of Medicine·T R FriedenS W Dooley
Feb 25, 1993·The New England Journal of Medicine·M GobleC R Horsburgh
Mar 30, 1993·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·K Ovreberg
Nov 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N SalomonD Mildvan
Mar 1, 1996·Indian Journal of Pediatrics·K Chopra

❮ Previous
Next ❯

Citations

Sep 29, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Tin Tin Su, Steffen Flessa
Mar 20, 2003·Health Policy·Martha AinsworthAgnes Soucat
May 22, 2003·Tuberculosis·Thomas R Frieden, Cynthia R Driver
Sep 5, 2007·Bulletin of the World Health Organization·Jay K VarmaJordan W Tappero
Oct 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Gwenan M KnightRichard G White
Mar 17, 2001·Tropical Medicine & International Health : TM & IH·K WyssN Lorenz
Apr 20, 2005·Clinics in Chest Medicine·Thomas R Frieden, Sonal S Munsiff
Sep 2, 2016·BMC Health Services Research·Qun WangManuela De Allegri
Jan 28, 1999·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·G M Cannon, P M Paris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.